ZNF713 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.772200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.394000E-01
Normal-vs-Stage2
5.721400E-01
Normal-vs-Stage3
2.758000E-01
Normal-vs-Stage4
3.504400E-01
Stage1-vs-Stage2
1.609990E-01
Stage1-vs-Stage3
7.313800E-02
Stage1-vs-Stage4
2.790800E-01
Stage2-vs-Stage3
3.090800E-01
Stage2-vs-Stage4
2.901700E-03
Stage3-vs-Stage4
6.528500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.982400E-01
Normal-vs-AfricanAmerican
7.288400E-01
Normal-vs-Asian
4.393000E-01
Caucasian-vs-AfricanAmerican
9.577800E-01
Caucasian-vs-Asian
3.373000E-01
AfricanAmerican-vs-Asian
4.830200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.417200E-01
Normal-vs-Female
7.333200E-01
Male-vs-Female
6.059200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.678200E-01
Normal-vs-Age(41-60Yrs)
8.400200E-01
Normal-vs-Age(61-80Yrs)
4.151400E-01
Normal-vs-Age(81-100Yrs)
2.823600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.000600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.100240E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.625800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.083600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.335500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.367800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.528200E-01
Normal-vs-Daily Drinker
4.802000E-01
Normal-vs-Weekly Drinker
7.318400E-01
Normal-vs-Occasional Drinker
8.581800E-01
Normal-vs-Social Drinker
9.325200E-01
Non Drinker-vs-Daily Drinker
8.980400E-01
Non Drinker-vs-Weekly Drinker
4.870600E-01
Non Drinker-vs-Occasional Drinker
7.447600E-02
Non Drinker-vs-Social Drinker
9.359500E-02
Daily Drinker-vs-Weekly Drinker
4.796600E-01
Daily Drinker-vs-Occasional Drinker
9.845900E-02
Daily Drinker-vs-Social Drinker
1.158230E-01
Weekly Drinker-vs-Occasional Drinker
3.758000E-01
Weekly Drinker-vs-Social Drinker
4.211200E-01
Occasional Drinker-vs-Social Drinker
8.032200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.544400E-01
Normal-vs-Grade 2
1.503420E-01
Normal-vs-Grade 3
1.580830E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.460600E-01
Grade 1-vs-Grade 3
8.245000E-01
Grade 1-vs-Grade 4
2.544400E-01
Grade 2-vs-Grade 3
5.458300E-02
Grade 2-vs-Grade 4
1.503420E-01
Grade 3-vs-Grade 4
1.580830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.480800E-01
Normal-vs-NonDiabetic
7.051800E-01
Diabetic-vs-NonDiabetic
2.442200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.333600E-01
Normal-vs-NoPancreatitis
6.217200E-01
Pancreatitis-vs-NoPancreatitis
9.902800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.820800E-01
Normal-vs-N1
6.637000E-01
N0-vs-N1
8.432600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.459600E-01
Normal-vs-TP53-NonMutant
8.801000E-01
TP53-Mutant-vs-TP53-NonMutant
4.202600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
